Background
==========

Conventional mechanical ventilation (CMV) is a core feature of intensive care. Weaning and removement of endotracheal tube are crucial processes, which often account for a considerable part of CMV total time. Unsuccessful extubation has been noted to be associated with an increase of both morbidity and mortality in adult and paediatric patients \[[@B1]-[@B4]\]. The documented rate of failed extubations ranges from 4.1 to 14% in paediatric intensive care units (PICUs) \[[@B1],[@B2],[@B5]\]. Therefore, strategies preventing the need for reintubation are needed.

Non invasive ventilation (NIV) has been proposed as a useful therapy to wean patients after unsuccessful weaning trials and to avoid reintubation in adults \[[@B6]-[@B10]\], though controversy exists at this concern \[[@B11],[@B12]\]. This technique is increasingly being used in paediatric patients over the last years \[[@B13]-[@B20]\]. Some of these studies have included children receiving NIV because of ARF secondary to multiple causes including postextubation cases \[[@B13],[@B14]\]. Other authors, however, excluded from the analysis postextubation NIV use \[[@B15]-[@B17]\] in accordance with NIV studies in adult patients and very low birth infants, which analyze postextubation NIV separately \[[@B6],[@B8]-[@B10],[@B21]-[@B23]\]. The reason provided to exclude these cases is that NIV characteristics are very different when applied after receiving CMV.

The objective of the present study was to determine postextubation NIV characteristics and to identify risk factors of postextubation NIV failure in children.

Methods
=======

A prospective observational study was conducted in our 8-bed paediatric intensive care unit (PICU) from July 2004 to December 2008 following NIV PICU protocol. To be enrolled, patients had to have undergone CMV for over 12 hours, to have adequate consciousness level (Glasgow coma score of greater than or equal to 10), to require no inotropics (or a maximum of 5 mcg/kg/minute of dopamine) and to fulfill NIV inclusion criteria, listed below. Extubation was performed following our internal PICU protocol for weaning: FiO~2~of less than or equal to 0.4 to maintain transcutaneous oxygen saturation \>94% (or baseline values in cyanotic cardiopathies), positive end-expiratory pressure (PEEP) under 8 cm H~2~O and a pressure support of under 12 cm H~2~O. An exception was made to this protocol: PEEP could be ≥ 8 cmH~2~O in children in whom an early extubation was considered beneficial due to high risk of associated-ventilator pneumonia (e.g. immunodeficiency). Sedation was progressively lowered according to our sedation protocol in order to avoid withdrawal syndrome.

Types of postextubation NIV were elective NIV (eNIV) when the patient was extubated directly to NIV, or rescue NIV (rNIV) when the child developed ARF within 48 hours after extubation.

Inclusion criteria
------------------

• eNIV: children deemed at high-risk of extubation failure (e.g. severe kyphoescholiosis, severe neuromuscular disorders) or patients extubated from a PEEP ≥ 8 cmH~2~O.

• rNIV: ARF within 48 hours after extubation which did not respond to aggressive medical treatment and: a respiratory rate above 2 standard deviations (SD) for child\'s age normal range, or a partial pressure of arterial oxygen to the fraction of inspired oxygen (PaO~2~: FiO~2~) ratio under 250 and above 150 or a transcutaneous oxygen saturation \<90% despite FiO~2~of 50%, or venous PCO~2~\> 55 mmHg or arterial PCO~2~\> 50 mmHg.

Criteria for reintubation
-------------------------

NIV was stopped and patients were intubated when oxygen saturation was below 90% or venous PCO~2~above 65 mmHg despite maximal NIV setting, or if management of secretions was inadequate, or if patency of airways could not be maintained, or when any of the exclusion criteria appeared.

Exclusion criteria
------------------

cardiorespiratory arrest, hemodynamic instability despite fluid load and vasoactive treatment, absence of cough reflex, Glasgow coma score lower than 10, vocal cords palsy, bullous neumopathy, pneumothorax and upper gastrointestinal tract active bleeding.

Underlying condition
--------------------

Patients were categorized in different subgroups according to their main underlying conditions before they were extubated. Each child could be classified in more than one subgroup. Neurologic: children with severe encephalopathy or severe neuromuscular disease; Respiratory: patients intubated due to pneumonia, asthma, bronchiolitis or with underlying bronchopulmonary dysplasia; Immunosupression; Cardiac: congenital cardiopathy; Severe scoliosis.

Monitoring
----------

All patients were continuously monitored by means of electrocardiography, pulse oximeter and respiratory rate. Blood gas analysis was only performed when considered necessary by the attending physician.

NIV technique
-------------

CPAP or pressure support ventilation was delivered using a nasal mask, face mask, or helmet device. The interface was chosen according to child\'s age and size achieving comfortability and avoiding air leaks. When using a mask, initially it was applied manually onto the patient\'s face, and then it was held by a paediatric head cap. Colloid dressings were placed on the major pressure points to minimize skin injury. A heated humidifier (Fisher and Paykel Healthcare, Auckland, New Zealand) was used in all cases. Ventilators employed were BiPAP Vision (Respironics, Pittsburgh, PA) for pressure support NIV and CF 800 (Dräger, Lübeck, Germany) for CPAP.

Ventilation strategy
--------------------

In eNIV, continuous positive airway pressure (CPAP) or expiratory positive airway pressure (EPAP) was set at 1-2 cmH~2~O higher than previous PEEP during CMV. In rNIV, CPAP or EPAP initial ventilator setting was 4-5 cmH~2~O. In both types of postextubation NIV, inspiratory positive airway pressure (IPAP) was started at 6-8 cmH~2~O. IPAP was increased if the attending physician considered that inspiratory volume was low according to auscultation and thoracic motion, and if hypercarbia increased or did not decrease. CPAP or EPAP were increased if no improvement of pulse-oximetry O~2~saturation or arterial PO~2~was achieved. If clinical situation did not improve with CPAP and a good-fitting mask was available, the child could be switched to pressure support NIV according to the attending physician\'s decision.

Data collection
---------------

Patients with multiple NIV episodes were considered individually, since each episode requiring NIV presents new variables potentially affecting outcome. For each episode, the following variables were collected: age, gender, weight, PICU stay, primary cause of intubation, underlying disease, type of postextubation NIV, paediatric risk of mortality (PRISM) score within 24 hours of admission, type of interface, NIV duration, NIV outcome, mortality and causes of death. Clinical data collected were respiratory rate (RR), heart rate (HR) and FiO~2~before NIV was started. The same data and CPAP, EPAP and IPAP were collected at 1, 6, 12, 24 and 48 hours.

Outcome
-------

NIV was considered successful when reintubation was avoided.

Statistical analysis
--------------------

Mean, median, standard deviation and range were used to describe the sample. Quantitative continuous variables were compared between groups using Mann Whitney\'s non parametric tests if the variable had a non-normal distribution or unpaired Student\'s t test if the variable had a normal distribution. Qualitative variables were compared by Chi-square test (χ^2^). A logistic regression analysis was performed in order to identify possible predictors of NIV failure. Kaplan-Meier estimate-of-survival curve was used to determine the cumulative risk of avoiding reintubation. Multiple logistic regression analysis was performed before NIV start and after 1, 6 and 12 hours. Variables included in the multivariate analysis were those which had a p value under 0.2 between success and failure groups and also those variables which were considered clinically important in order to control statistical confusion. Variables included in the model were age, weight, gender, HR difference to initial HR, RR difference to initial RR, FiO~2~, neurologic condition, type of postextubation NIV. At the first hour, IPAP was also included. Before NIV was started, RR and HR were also included, instead of HR or RR difference. PO~2~/FiO~2~ratio, PCO~2~and pH were excluded from multivariate analysis due to the lack of data. A p value \< 0.05 was considered statistically significant.

This research project was approved by the Research Ethics Committee of the Hospital Universitario Central de Asturias. Written informed consent was obtained from patients\' parents or guardians.

Results
=======

During the study period, there were 1255 admissions in our PICU. Two hundred and thirty-eight children received CMV. Of these, 45 episodes received postextubation NIV. Three of them were excluded because they received CPAP by means of a different flow system ventilator (Infant Flow™ system). Another episode was also excluded because inclusion criteria were not fulfilled. Among those resulting 41 episodes (36 patients), 20 of them belonged to rNIV group. CPAP was only used in two cases (one failed after switching to pressure support NIV). Baseline characteristics are shown in Table [1](#T1){ref-type="table"}.

###### 

Baseline characteristics of the sample.

                                   Whole sample (N = 41)   Elective NIV (N = 21)   Rescue NIV (N = 20)   P value
  -------------------------------- ----------------------- ----------------------- --------------------- ---------
  **Patients\' characteristics**                                                                         
                                                                                                         
  Age (months)                     20.9 (0.5-206.8)        15.8(0.5-195.4)         44.5 (0.8-206.8)      0.160
  Males (%)                        63.4                    52.4                    75.0                  0.133
  Weight (kg)                      17.9 ± 16.5             13.9 ± 12.8             22.0 ± 19.1           0.124
  PRISM score                      11.2 ± 7.3              8.9 ± 6.4               13.6 ± 7.5            0.038
  CMV duration (hours)             139.2 ± 98.4            139.9 ± 112.8           137.7 ± 81.6          0.946
  HR (beats/min)                   131.6 ± 30.4            129.0 ± 27.1            134.4 ± 34.0          0.580
  RR (breaths/min)                 32.6 ± 13.7             31.3 ± 11.7             34.1 ± 15.8           0.524
  FiO~2~(%)                        36.4 ± 13.3             38.2 ± 17.1             34.5 ± 7.5            0.375
  PCO~2~(mmHg)                     52.5 ± 11.2             51.4 ± 7.3              53.6 ± 13.3           0.600
  PO~2~/FiO~2~ratio                336.1 ± 146.7           291.9 ± 136.5           350.1 ± 163.1         0.614
  pH                               7.36 ± 0.11             7.41 ± 0.02             7.35 ± 0.12           0.525
                                                                                                         
  **Underlying conditions - no**                                                                         
                                                                                                         
  None                             9                       6                       3                     
  Neurologic                       14                      6                       8                     
  Respiratory                      21                      14                      7                     
  Immunosupression                 3                       2                       1                     
  Cardiac                          1                       1                       0                     
  Severe scoliosis                 5                       1                       4                     

P value refers to the differences between elective and rescue NIV groups. Parameters are expressed in mean ± standard deviation except for age and CMV duration (median and range) and gender (%). Note that the addition of patients with underlying conditions exceeds the total number of patients because each patient might be included in different subgroups (see Methods section).NIV: non invasive ventilation; PRISM: paediatric risk of mortality (score); CMV: conventional mechanical ventilation; HR: heart rate; RR: respiratory rate; FiO~2~: fraction of inspired oxygen; PCO~2~: arterial partial pressure of oxygen dioxide; PO~2~: arterial partial pressure of oxygen.

NIV was successful in 65.9% of cases. Baseline characteristics of success and failure groups are shown in Table [2](#T2){ref-type="table"}. Rate of success was significantly different between rNIV and eNIV groups (50% vs 81%; p = 0.037). Figure [1](#F1){ref-type="fig"} shows cumulative probability of avoiding reintubation related to rNIV and eNIV groups. In 3 episodes, extubation was performed from a PEEP over 8 cmH~2~O and eNIV was applied. None of these 3 cases failed NIV trial.

![**Kaplan-Meier estimate-of-survival curve comparing the cumulative risk of avoiding reintubation regarding types of postextubation non-invasive ventilation: rNIV in discontinuous line and eNIV in continuous line**. NIV: non-invasive ventilation.](1471-2431-10-29-1){#F1}

###### 

Baseline characteristics of success and failure groups.

  --------------------------------------------------------------------------------------------------
                                             Success group\       Failure group (N = 14)   P value
                                             (N = 27)                                      
  ------------------------------------------ -------------------- ------------------------ ---------
  **Patients\' characteristics**                                                           

  Age (months)                               30.4 (0.5 - 206.8)   11.5 (0.8 - 199.2)       0.947

  Males (%)                                  56.0                 78.6                     0.096

  Weight (kg)                                17.4 ± 15.8          18.7 ± 18.4              0.811

  PRISM score                                10.5 ± 7.2           12.7 ± 7.5               0.360

  HR (beats/min)                             130.2 ± 30.4         134.3 ± 31.4             0.688

  RR (breaths/min)                           34.6 ± 14.9          28.4 ± 10.1              0.187

  FiO~2~(%)                                  36.0 ± 9.3           37.0 ± 19.1              0.823

  PCO~2~(mmHg)                               54.6 ± 11.8          46.6 ± 3.4               0.177

  PO~2~/FiO~2~ratio                          337.8 ± 168.1        284.8 ± 77.9             0.381

  pH                                         7.35 ± 0.11          7.44 ± 0.05              0.259

                                                                                           

  **Primary cause of intubation - no (%)**                                                 

  Postsurgery                                8 (29.6)             3 (21.4)                 

  Bronchiolitis                              4 (14.8)             4 (28.6)                 

  Pneumonia                                  5 (18.5)             1 (7.1)                  

  Severe cranial trauma                      1 (3.7)              2 (14.3)                 

  ARDS                                       2 (7.4)              0 (0)                    

  CPR                                        2 (7.4)              0 (0)                    

  Central apneas                             0 (0)                2 (14.3)                 

  Upper airways respiratory infection        2 (7.4)              0 (0)                    

  Others                                     3 (11.2)             2 (14.3)                 

                                                                                           

  **Underlying conditions - no (%)**                                                       

  Neurologic                                 6 (22.2)             8 (57.1)                 0.025

  Respiratory                                17 (63.0)            7 (50.0)                 0.424

  Immunosupression                           3 (11.1)             0 (0.0)                  0.539

  Cardiac                                    0 (0)                1 (7.1)                  0.341

  Severe scoliosis                           3 (11.1)             2 (14.3)                 0.768

                                                                                           

  **Type of postextubation**\                                                              0.037
  **NIV - no (%)**                                                                         

  Elective NIV                               17 (81)              4 (19)                   

  Rescue NIV                                 10 (50)              10 (50)                  
  --------------------------------------------------------------------------------------------------

PRISM: paediatric risk of mortality (score); HR: heart rate; RR: respiratory rate; FiO~2~: fraction of inspired oxygen; PCO~2~: arterial partial pressure of oxygen dioxide; PO~2~: arterial partial pressure of oxygen; ARDS: acute respiratory distress syndrome; CPR: cardiopulmonary resuscitation; NIV: non invasive ventilation

Causes of NIV failure were upper airway obstruction in 5 cases, apnoeas in 3 children, hypercapnia in 2, and hemodynamic instability, hypoxemia, inability to manage secretions and massive atelectasis in 1 episode each. Median period between NIV beginning and reintubation was 4.5 hours (range 0.2 - 19 hours). Mean stay was 19.0 ± 17.7 days in success group vs. 45.3 ± 39.3 days in failure group (p = 0.001). Facial mask was used in 30 cases (13 in rNIV), nasal mask in 5 (3 in rNIV), full-face mask in 2 (1 in rNIV) and helmet in 2 (both in rNIV). Median NIV duration was 12 hours (range 0.2 - 149 hours). Two deaths occurred during the study, both children belonging to failure group. None of these deaths was related to NIV use or to NIV failure.

Table [3](#T3){ref-type="table"} shows clinical variables with statistically significant differences in univariate analysis between success and failure groups. FiO~2~at 1 hour was found to have an area under the curve (AUC) of 0.836 to detect NIV failure. A FiO~2~of 50% at 1 hour could predict NIV failure with a sensitivity of 76.9% and specifity of 81.5%. RR decrease at 6 hours had an AUC of 0.764 to predict NIV success. A decrease of RR at 6 hours equal to or higher than 4 bpm could predict NIV success with a sensitivity of 92.3% and specifity of 57.1%.

###### 

Parameters with significant differences between success and failure groups expressed in mean ± standard deviation.

  ---------------------------------------------------------------------------------------------------
                                         Success group (N = 27)   Failure group (N = 14)   P value
  -------------------------------------- ------------------------ ------------------------ ----------
  RR decrease at 6 hours (breaths/min)   7.1 ± 9.6\               -4.0 ± 12.2\             0.015
                                         (N = 27)                 (N = 7)                  

  FiO~2~at 1 hour                        36.9 ± 9.2\              72.7 ± 29.3\             \< 0.001
                                         (N = 27)                 (N = 13)                 

  PO~2~/FiO~2~ratio at 6 hours           282.6 ± 74.8\            136.4 ± 10.8\            0.012
                                         (N = 8)                  (N = 3)                  
  ---------------------------------------------------------------------------------------------------

Number of episodes analyzed in each item is specified below. RR: respiratory rate; FiO~2~: fraction of inspired oxygen; PO~2~: arterial partial pressure of oxygen.

Multiple logistic regression analysis revealed that no variable included in the model was an independent predictive factor of postextubation NIV success or failure.

Discussion
==========

Data about postextubation NIV use in children are scarce. We conducted the present study following an observational design, as patients\' management was based on our standard clinical practice criteria. To our knowledge, this is the first study to identify predictive factors of postextubation NIV outcome in a multidisciplinary PICU. Previous pediatric studies about NIV use after extubation focus on post-cardiac surgery patients \[[@B18],[@B24]\].

Postextubation NIV can be used in three ways: (1) as an adjunct to weaning patients from CMV by early extubation directly to NIV, (2) as a preventive application of NIV to higher-risk patients who were extubated at the time they fulfilled standard extubation criteria, or (3) as a curative or rescue application of NIV to patients who develop ARF after having been extubated according to standard criteria. The first two indications represent children included in our study as eNIV cases. The third indication corresponds to rNIV group.

Rate of success (65.9%) was lower than rates reported in other NIV pediatric studies which do not include postextubation cases \[[@B15],[@B17]\]. A very similar success rate was reported by Essouri in the subgroup of patients with respiratory failure after extubation \[[@B13]\] and by Pons in children after cardiac surgery \[[@B18]\]. This suggests that these patients must be even more carefully monitored than those with no previous CMV. Furthermore, a remarkable observation from our study was that all cases which required reintubation failed NIV trial in the first hours (Figure [1](#F1){ref-type="fig"}). Therefore, identification of early risk factors for NIV failure is very important in order to avoid an urgent or delayed reintubation, which seems to be associated with higher mortality in adult patients with extubation failure \[[@B25]\]. Conversely, if reintubation is avoided in the first 12 hours after extubation, NIV is likely to be successful.

We found that children developing ARF after extubation non-respondent to conventional medical therapy (rNIV) were more likely to fail NIV support than those extubated directly to NIV (eNIV). This goes in accordance with previous studies in adult patients. Keenan and Esteban found no outcome improvement in patients treated with NIV who developed ARF in the following 48 h after extubation when compared with standard medical therapy \[[@B8],[@B9]\]. Trevisan reported the effectiveness of NIV after unsuccessful weaning trials when applied directly after extubation \[[@B6]\] and Nava described a lower rate of reintubation in a population considered at risk of developing postextubation respiratory failure in NIV group in comparison with standard medical therapy \[[@B7]\]. By contrast, our results suggest that eNIV and rNIV might be considered as two different populations regarding NIV management and effectiveness. It should be outlined that some patients in eNIV group might have avoided intubation without using NIV, but NIV\'s potential secondary effects are mild and NIV seems to be beneficial after extubation \[[@B18],[@B24]\].

Patients with underlying neurologic conditions were found to be at higher risk for reintubation. Kurachek et al. reported the same patient feature associated with extubation failure \[[@B1]\]. Similar finding have been made in adult patients \[[@B26]\], and some reasons provided to explain this fact are pharyngeal hypotonia and diminished cough strenght and secretions clearance in these patients \[[@B1],[@B26]\].

Evolution of RR in the first hours was described as an outcome predictor in several paediatric studies \[[@B13],[@B15]\]. The other clinical variable identified as a risk factor in the current study was an increase in oxygen requirements. This outcome predictor has been already reported in patients with no previous CMV \[[@B15],[@B16]\]. Also arterial PO~2~/FiO~2~was significantly higher in success group in the first hour, which goes in accordance with other works in hypoxemic patients \[[@B17]\].

Some limitations of this study must be outlined. First, the power of the study is limited due to the sample size, which obligates us to take our results with caution. Second, it is not a randomized trial, which would be definitive to draw conclusions. Taking into account that postextubation NIV seems to be beneficial \[[@B24]\], performing such study could be problematic. Third, due to the fact of being an observational study, blood gas analysis were performed only if considered necessary by the attending physician. Lastly, different interfaces were used, but we consider that no NIV failure could be attributable to this. However, it must be noted that incorrect interface choosing might influence NIV outcome.

This study has several strengths. First, it is the first study focusing on paediatric postextubation NIV outcome predictors. Second, the current prospective study is based on daily clinical practice, which may allow the findings to be useful for clinical management of these children. Furthermore, despite the observational design, inclusion and reintubation criteria were well defined following our internal protocol.

Conclusions
===========

In conclusion, our data suggest that postextubation NIV seems to be useful in avoiding reintubation in high-risk children when applied immediately after extubation. NIV was more likely to fail when ARF has already developed (rNIV), when RR at 6 hours did not decrease and if oxygen requirements increased. Neurologic patients seem to be at higher risk of reintubation despite NIV use.
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